|Articles|September 25, 2020

Medicare Advantage Continues to Offer More Choices, Lower Premiums to America’s Seniors

The average Medicare Advantage monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums.

WASHINGTON – CMS announced yesterday its estimated 2021 monthly Medicare Advantage (MA) premiums. According to the agency, the average MA monthly premium in 2021 will be $21, a 11% decrease from 2020 premiums and a 34% reduction from 2017 premiums. In addition, CMS announced that the average number of plan choices per county will increase from 39 plans in 2020 to 47 plans in 2021. Overall, nearly 5000 MA plans will be available across the country in 2021.

CMS also announced that MA enrollment is projected to reach approximately 26.9 million enrollees next year, up from 24.4 million enrollees in 2020. That means that MA will cover 42% of all Medicare beneficiaries.

“America’s seniors are increasingly choosing Medicare Advantage because it delivers better services, better access to care, and better value,” said Matt Eyles, president and CEO of America’s Health Insurance Plans. “And polls show that people in Medicare Advantage are overwhelmingly satisfied with their plan. That’s why we’ll continue to fight for a strong and stable program—both now and in the future.”

Latest CME

On-Demand Webinar

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

1.0 Credit / Neurology

On-Demand Webinar

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology

On-Demand Webinar

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

Online Article

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

2.0 Credits / Human Trafficking, Law

Webinar Registration

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

August 13, 2025 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

August 19, 2025 | 1:00 PM & 8:00 PM ET

Webinar Registration

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

August 21, 2025 | 1:00 PM ET & 8:00 PM ET

AJMC Supplement

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

On-Demand Panel Discussion

An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment

1.5 Credits / Breast Cancer, Oncology

On-Demand Webinar

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

On-Demand Webinar

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

AJMC Supplement

Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements

2.0 Credits / Psychiatry

AJMC Supplement

Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia

3.0 Credits / Psychiatry

Medicare Advantage Continues to Offer More Choices, Lower Premiums to America’s Seniors

Newsletter

Related Articles

Latest CME

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

Prescription Digital Therapeutics in Schizophrenia: A Managed Care Perspective on Advancements

Navigating Innovations: A Managed Care Perspective Addressing the Economic Burden of Schizophrenia

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Overview and Burden of Migraine

The Role of the Pharmacist Migraine Management

The Evolving Treatment Landscape of Migraine

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

Trending on AJMC

Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia

West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations

Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology

Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD

Disparities in Physician Access for Rheumatology, Dermatology, and Gastroenterology: A Systematic Review